MODERN LONG-TERM PROPHYLAXIS AND TREATMENT OPTIMIZATION BASED ON REAL WORLD EXPERIENCE
Date: February 20th, 2024
Time: 5 pm to 6 pm CET
ACARE Make A Difference is an eleven-part webinar series with a primary focus on the diagnostic evaluation of patients experiencing recurrent angioedema, including those with hereditary angioedema (HAE), as well as the enhancement of therapy control and optimization. The overarching goal of this webinar series is to facilitate the provision of optimal therapy to all individuals afflicted with recurrent angioedema, particularly those affected by HAE, at the earliest possible stage.
Throughout the series, various topics are explored, including strategies to expedite the diagnosis process and reduce instances of misdiagnosis, methods for family screening in HAE patients, the implementation of closely monitored therapy control measures, and guidance on the continual refinement of therapeutic approaches.
This specific webinar will place special emphasis on the updated and comprehensive classification and terminology of angioedema.
TOPICS and SPEAKERS
Prof. Dr. Marcus Maurer: Introduction
Dr. Stefan Cimbollek: C1-Inhibitor and Long-Term Prophylaxis in real life.
Dr. Mauro Cancian: Lanadelumab and Long-Term Prophylaxis adaption.
Dr. Emel Aygören Pursun: Oral treatments advantages/disadvantages compared to Long-Term Prophylaxis.
All faculty: Q&A